Table 4 Multivariable analysis of predictors for recipient overall survival
HR (95% CI) | P value | |
|---|---|---|
Donor age (reference Group I) | < 0.001 | |
Group II | 1.087 (0.979–1.208) | 0.119 |
Group III | 1.124 (1.015–1.246) | 0.025 |
Group IV | 1.395 (1.215–1.602) | < 0.001 |
Recipient age | 1.021 (1.014–1.027) | < 0.001 |
Recipient race (reference White) | 0.013 | |
Black or African American | 1.141 (1–1.301) | 0.050 |
Asian | 0.878 (0.726–1.062) | 0.181 |
Hispanic/Latino | 0.882 (0.783–0.993) | 0.038 |
Other | 1.178 (0.85–1.633) | 0.326 |
Underlying liver diseases (reverence HCV) | 0.011 | |
HBV | 0.724 (0.596–0.879) | 0.001 |
Alcoholic liver diseases | 0.935 (0.803–1.088) | 0.383 |
NASH | 0.878 (0.748–1.029) | 0.108 |
Other | 0.992 (0.864–1.138) | 0.904 |
MELD | 1.013 (1.006–1.019) | < 0.001 |
Recipient serum creatinine (mg/dl) | 1.051 (1.008–1.095) | 0.019 |
Sum of tumor diameters (cm) | 1.052 (1.033–1.072) | < 0.001 |
AFP (≥ 400 ng/ml vs. < 400 ng/ml) | 1.993 (1.648–2.412) | < 0.001 |
Tacrolimus maintenance at discharge | 0.911 (0.835–0.994) | 0.035 |
Steroids maintenance at discharge | 0.762 (0.696–0.835) | < 0.001 |